Summit Trail Advisors’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,465
Closed -$262K 618
2024
Q1
$262K Buy
+4,465
New +$262K 0.01% 503